Literature DB >> 22605696

Transdermal hyoscine induced unilateral mydriasis.

Breffni Hannon1, Valerie Jennings, Marie Twomey, Maeve O'Reilly.   

Abstract

The authors present a case of unilateral mydriasis in a teenager prescribed transdermal hyoscine hydrobromide (scopolamine) for chemotherapy induced nausea and vomiting. The authors discuss the ocular side-effects associated with this particular drug and delivery system and the potential use of transdermal hyoscine as an antiemetic agent in this group.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22605696      PMCID： PMC3316802          DOI： 10.1136/bcr.08.2011.4697

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  6 in total

1.  Unilateral mydriasis caused by transdermal scopolamine.

Authors:  M M Rubin; R S Sadoff; G M Cozzi
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1990-11

2.  Accidental mydriasis from scopolamine patches.

Authors:  N B Rosen
Journal:  J Am Optom Assoc       Date:  1986-07

3.  Scopolamine patch-induced unilateral mydriasis.

Authors:  E A Thiele; J J Riviello
Journal:  Pediatrics       Date:  1995-09       Impact factor: 7.124

4.  Results of a randomized double-blind crossover trial of scopolamine versus placebo administered by transdermal patch for the control of cisplatin-induced emesis.

Authors:  D L Longo; M Wesley; D Howser; S M Hubbard; T Anderson; R C Young
Journal:  Cancer Treat Rep       Date:  1982-11

5.  [Coma with bilateral mydriasis after use of transdermal scopolamine in ICU].

Authors:  X Repéssé; T Geeraerts; J Pottecher; B Vigué; D Benhamou; J Duranteau
Journal:  Ann Fr Anesth Reanim       Date:  2007-10-24

Review 6.  Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546
  6 in total
  1 in total

1.  Anisocoria secondary to inadvertent contact with scopolamine patch.

Authors:  Janki Shah; Alice Jiang; Zoltan Fekete
Journal:  BMJ Case Rep       Date:  2017-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.